L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
98,600
+1,600 (1.65%)
At close: Feb 27, 2026
325.00%
Market Cap 2.45T
Revenue (ttm) 79.99B
Net Income (ttm) 78.00B
Shares Out 24.84M
EPS (ttm) 3,050.54
PE Ratio 32.04
Forward PE n/a
Dividend 50.00 (0.05%)
Ex-Dividend Date Dec 29, 2025
Volume 793,313
Average Volume 680,749
Open 94,500
Previous Close 97,000
Day's Range 94,500 - 98,900
52-Week Range 18,490 - 125,000
Beta 1.47
RSI 59.19
Earnings Date Feb 13, 2026

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 141
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2024, L&C BIO Co.,LTD's revenue was 72.09 billion, an increase of 9.35% compared to the previous year's 65.93 billion. Earnings were 141.06 billion, an increase of 191.69%.

Financial Statements

News

There is no news available yet.